Cover Image

Vaccines 2011: World Market Analysis, Key Players, and Critical Trends in a Fast-Changing Industry

Abstract

The high growth rates and successful launch of several products recently has kept interest in the global vaccine market high. The global market for vaccines experienced strong growth through 2010 and this is expected to continue through the forecast period. Growth is being fueled by new product introductions and rising usage in all regions.

Kalorama Information has been closely following vaccine markets and since 2003 has instituted a yearly market research report schedule to keep up with fast-moving developments. Our latest comprehensive update, Vaccines 2011: World Market Analysis, Key Players, and Critical Trends in a Fast-Changing Industry, examines the market for vaccines used in humans for various disease. This state-of-the-industry report is a must-have for any executive who wants to stay on top of a rapidly changing market and see what' s expected based on analysis of major company pipelines.

Trends are discussed in this report including the introduction of needle-free systems and the production of vaccines, as well as product safety, supply shortages, and the use of vaccines to prevent pandemics and address bioterrorism, and innovations in vaccine delivery systems. News and reports of vaccine-related illness tend to exacerbate the public' s fears and result in higher rates of non-immunization, and these are discussed in this edition of the report.

The report covers only commercialized vaccines and developmental vaccines for diseases that are already vaccine-preventable; it does not cover emerging vaccines for diseases that are not currently vaccine-preventable.

Included in this report are current market size and forecast for the following vaccines:

Pediatric Vaccines:

  • Combinations
  • Hepatitis
  • HIB
  • MMR
  • Pneumococcal
  • Poliovirus
  • Varicella
  • Other Pediatric

Adult Vaccines:

  • Cervical Cancer
  • Hepatitis
  • Influenza
  • Pneumococcal
  • Travel; DT; Misc.

Important trends such as vaccine safety, vaccine shortages, preventing pandemics, vaccines and bioterrorism, DNA vaccination, innovations in vaccine delivery systems and innovations in vaccine Production are covered in the report.

Kalorama has expanded the global perspective of this report in this edition, including estimates of vaccine sales (pediatric and adult segments) in the following regions:

  • U.S.
  • Rest of North Amer.
  • South America
  • Europe
  • Japan
  • India
  • China
  • Rest of World

In addition, the report profiles key competitors in the vaccine industry. Companies profiled in the report include:

  • AlphaVax, Inc.
  • Bavarian Nordic A/S
  • Baxter Healthcare
  • Bharat Biotech
  • Celldex Therapeutics
  • Crucell / Johnson and Johnson
  • Emergent biosolutions
  • GlaxoSmithKline
  • Medimmune
  • Merck & Co. Inc
  • Nabi Biopharmaceuticals
  • Novartis
  • Pfizer
  • Sanofi Pasteur

Revenue estimates for each market segment represent global revenues and are expressed in current dollars. Estimates are provided for the historic 2005 to 2009 period and forecasts are provided through 2014. Historical information for this report was gathered from a wide variety of published sources including company reports and filings, government documents, legal filings, trade journals, newspapers and business press, analysts' reports and other sources. Interviews with company representatives and other experts were conducted to capture the perspectives from industry participants' point of view and assess trends... these form the basis of the forecasting and competitive analysis.

Table of Contents

EXECUTIVE SUMMARY

  • THE GLOBAL VACCINES INDUSTRY
    • Scope and Methodology
    • Overview
    • Pediatric Preventative Vaccines
  • The Market
  • The Market
  • Total Market
  • Issues and Trends

CHAPTER TWO: INTRODUCTION TO VACCINES

  • A Brief History: The Development of Vaccines
  • The Immune Response
  • Mechanism of Action
  • Types of Vaccines
    • Attenuated (Weakened) Live Viruses
    • Killed (Inactivated) Viruses
    • Toxoid Vaccines
    • Genetically Engineered/Modified Vaccines
      • Subunit Vaccines
      • Conjugate Vaccines
      • DNA Vaccination
    • Vaccine Approval Process

CHAPTER THREE: PEDIATRIC PREVENTIVE VACCINES

  • Introduction
  • Childhood Immunization in the United States
    • Childhood Immunization Rates
    • Challenges to the Vaccine Delivery System
    • The Effect of U.S. Healthcare Reform
    • Recommended Childhood Immunization Schedule
    • State Immunization Recommendations
    • United Nations Initiatives
  • Pediatric Vaccine Products
    • BCG
    • Diphtheria, Tetanus, Pertussis, Hepatitis B and Polio
      • Diphtheria
      • Pertussis
      • Tetanus
      • Hepatitis B
      • Poliomyelitis
      • Enterotoxigenic Escherichia coli
    • Haemophilus Influenzae Type B
    • Hepatitis A
    • Measles, Mumps and Rubella
      • Measles
      • Mumps
      • Rubella
    • Meningococcal Disease
    • Parainfluenza Virus Type 3
    • Pneumococcal Conjugate
    • Rotavirus
    • Respiratory Syncytial Virus
    • Varicella
  • Pediatric Vaccines in Development
  • Cost of Vaccines in the United States
  • The World Market for Pediatric Preventive Vaccines
    • Total Market Size and Forecast
    • Hepatitis Vaccine Market
      • Market Analysis
      • Leading Products and Competitors
    • Haemophilus Influenzae Type B Vaccine Market
      • Market Analysis
      • Leading Products and Competitors
    • Measles, Mumps and Rubella Vaccines
      • Market Analysis
    • Combination Vaccines Market
      • Market Analysis
      • Leading Products and Competitors
    • Pneumococcal Vaccine
      • Leading Products and Competitors
    • Poliovirus Vaccine
      • Market Analysis
      • Leading Products and Competitors
    • Varicella Vaccines
      • Market Analysis
      • Leading Products and Competitors
    • Other Vaccines Market
      • Market Analysis
      • Leading Products and Competitors

CHAPTER FOUR: ADULT PREVENTIVE VACCINES

  • Introduction
  • Adult Vaccine-Preventable Diseases: Facts and Figures
  • Global Influenza Surveillance Program
    • U.S. Surveillance
  • Recommendations for Adult Immunizations
    • WHO International Health Regulations
  • Adult Vaccine Products
    • Allergies
    • Cervical Cancer
    • Cholera
    • Dengue Fever
    • Diphtheria-Tetanus
    • Hepatitis
      • Hepatitis A
      • Hepatitis B
    • Influenza
    • Japanese Encephalitis
    • Malaria
    • Pneumococcal Disease
    • Rabies
    • Shingles
    • Typhoid Fever
    • Yellow Fever
  • Adult Vaccines in Development
  • Total Market Size and Forecast
    • Cervical Cancer Market
    • Market Analysis
    • Leading Products and Competitors
  • Hepatitis Market
    • Market Analysis
    • Leading Products and Competitors
  • Influenza Vaccine Market
    • Market Analysis
    • Leading Products and Competitors
    • Market Analysis
    • Leading Products and Competitors
  • Travel, DT, and Miscellaneous Vaccine Market
    • Market Analysis
    • Leading Products and Competitors

CHAPTER FIVE: VACCINES MARKET SUMMARY

  • Trends Driving the Vaccines Market
  • Market Size and Forecast
    • Vaccine Sales by Region
    • Vaccine Market Competitors
    • Pediatric Vaccines
    • Major Manufacturers' Market Share
  • Adult Vaccines
  • Major Manufacturers' Market Share

CHAPTER SIX: ISSUES AND TRENDS

  • Vaccine Safety
    • Refusal to Immunize
    • Obesity
    • Post-Licensure Surveillance
      • Vaccine Adverse Event Reporting System
      • The Vaccine Safety Datalink Project
      • Phase IV studies
    • The Vaccine Injury Compensation Program
      • Countermeasures Injury Compensation Program
    • World Health Organization
    • Other Initiatives
    • The Future of Vaccine Safety
  • Vaccine Shortages
    • Preventing Shortages in the Developed Countries
      • Financial incentives
      • Equitable pricing
      • Vaccine stockpiles
    • Preventing Shortages in Developing Nations
      • Vaccine bonds
    • Preventing Pandemics
      • U.S. National Vaccine Plan
    • Vaccines and Bioterrorism
      • Overview
      • Project Bioshield Act
      • National Bio and Agro-Defense Facility
      • Vaccine Treatment and Evaluation Units
      • Anthrax
      • Smallpox
      • Tularemia
      • Viral Hemorrhagic Fevers
  • DTC Advertising of Vaccines
  • DNA Vaccination
  • Innovations in Vaccine Delivery Systems
    • Edible Vaccines
    • Mucosal Delivery
    • Intranasal Delivery
    • Vaccine Patches
    • Vaccine Chips
  • Innovations in Vaccine Production
    • Tobacco Plants
    • Insects
    • Nanoparticle Systems
    • Cloning

CHAPTER SEVEN: COMPANY PROFILES

  • AlphaVax, Inc.
    • History and Lines of Business
    • Strategic Alliances
    • Vaccine Products
    • Financial Information
  • Bavarian Nordic A/S
    • History and Lines of Business
    • Strategic Alliances
    • Vaccine Products
    • Financial Information
  • Baxter Healthcare
    • History and Lines of Business
    • Strategic Alliances
    • Vaccine Products
    • Financial Information
  • Bharat Biotech
    • History and Lines of Business
    • Strategic Alliances
    • Vaccine Products
    • Financial Information
  • Celldex Therapeutics
    • History and Lines of Business
    • Strategic Alliances
    • Vaccine Products
    • Financial Information
  • Crucell /Johnson & Johnson
    • History and Lines of Business
    • Strategic Alliances
    • Vaccine Products
    • Financial Information
  • Emergent biosolutions
    • History and Lines of Business Strategic Acquisition and Alliance
    • Vaccine Products
    • Financial
  • GlaxoSmithKline
    • History and Lines of Business
    • Strategic Alliances
    • Vaccine Products
    • Financial Information
  • Medimmune
    • History and Lines of Business
    • Strategic Alliances
    • Vaccine Products
    • Financial Information
  • Merck & Co. Inc
    • History and Lines of Business
    • Strategic Alliances
    • Vaccine Products
    • Financial Information
  • Nabi Biopharmaceuticals
    • History and Lines of Business Strategic Alliance
    • Vaccine Products
    • Financial Information
  • Novartis
    • History and Lines of Business
    • Strategic Alliances
    • Vaccine Products
    • Financial Information History and Lines of Business
    • Strategic Alliances
    • Vaccine Products
    • Financial Information
  • Sanofi Pasteur
    • History and Lines of Business
    • Strategic Alliances
    • Vaccine Products
    • Financial Information

COMPANY DIRECTORY

LIST OF EXHIBITS

CHAPTER ONE: EXECUTIVE SUMMARY

  • Figure 1-1: World Market for Pediatric Vaccines 2005-2014 Revenues
  • Figure 1-2: World Market for Adult Vaccines 2005-2014 Revenues

CHAPTER TWO: INTRODUCTION TO VACCINES

  • Table 2-1: Impact of Vaccines in the 20th Century Annual Morbidity in the 20th Century vs 2010
  • Figure 2-1: Attenuated Virus Production
  • Table 2-2: Vaccine-Preventable Diseases, June 2011
  • Table 2-3: VAERS Table of Reportable Events Following Vaccination

CHAPTER THREE: PEDIATRIC PREVENTIVE VACCINES

  • Table 3-1: Global Immunization Rates by Vaccine Type (DPT3, BCG, HepB, Yellow Fever, Tetanus, Hib, MCV, Polio) 2009
  • Table 3-2: Immunization Profile of the United States: Population by Age Group, Number of Vaccine-Preventable Diseases Reported by Disease 1990 - 2009
  • Table 3-3: U.S. Recommended Immunization Schedule for Children Ages 0 Through 6 Years, 2011
  • Table 3-4: U.S. Recommended Immunization Schedule for Adolescents Ages 7 to 18 Years, 2011
  • Table 3-5: Selected Pediatric Vaccines in Development, June 2011
  • Table 3-6: World Market for Pediatric Vaccines, 2006-2015..
  • Figure 3-1: Market Share of Pediatric Vaccines by Type 2010
  • Figure 3-2: Market Share of Pediatric Vaccines, by Type 2015
  • Table 3-7: World Market for Pediatric Vaccines by Region (U.S., Rest of North America, South America, EU, Japan, India, China, Rest of World) 2006-2015 Revenues
  • Table 3-8: World Pediatric Hepatitis Vaccine Market 2006-2015
  • Table 3-9: World Hib Vaccine Market, 2006-2015
  • Table 3-10: World MMR Vaccines Market 2006-2015
  • Table 3-11: World Combination Vaccines Market 2006-2015
  • Table 3-12: World Pediatric Pneumococcal Vaccine Market 2006-2015
  • Table 3-13: World Poliovirus Vaccine Market 2006-2015
  • Table 3-14: World Varicella Vaccine Market 2006-2015
  • Table 3-15: World Pediatric Other Vaccines Market 2006-2015

CHAPTER FOUR: ADULT PREVENTIVE VACCINES

  • Table 4-1: Universal Adult Immunization Schedule 2011
  • Table 4-2: Adult Immunization Schedule for Populations with Special Medical Conditions, 2011
  • Table 4-3: Initiatives to Require HPV Vaccination by U.S. State, 2011
  • Table 4-4: WHO Pandemic Classification Schedule
  • Table 4-5: Selected Adult Preventive Vaccines in Development, 2011
  • Table 4-6: World Market for Adult Preventive Vaccines, 2006-2015
  • Figure 4-1: Market Share of Adult Vaccines, by Type, 2010
  • Figure 4-2: Market Share of Adult Vaccines, by Type, 2015
  • Table 4-7: World Market for Adult Vaccines by Region (U.S., Rest pf North Amer., South America, EU, Japan, India, China, Rest of World) 2006-2015
  • Table 4-8: World Cervical CancerVaccine Market 2006-2015
  • Table 4-9: World Hepatitis Vaccine Market 2006-2015
  • World Influenza Vaccine Market 2006-2015
  • Table 4-11: 2010 Estimated Population by Region (Africa, Asia, Europe, N. America, Oceania, South America) and Selected Age Group (in millions)
  • Table 4-12: World Pneumococcal Vaccine Market 2006-2015
  • World Travel; Diphtheria-Tetanus; Miscellaneous Vaccines Market 2006-2015

CHAPTER FIVE: VACCINES MARKET SUMMARY

  • Figure 5-1: Sales Growth of Vaccines vs. Pharmaceuticals 2006-2015
  • Figure 5-2: World Market for Vaccines by Type 2006-2015
  • Table 5-1: The World Vaccines Market by Vaccine Type 2006-2015
  • Figure 5-3: World Market for Vaccines Share by Type (Pediatric, Adult), 2006, 2010 and 2015
  • Table 5-2: The World Vaccines Market by Region (U.S, Rest of North Amer., South America, EU, Japan, India, China, ROW) 2006-2015 Revenues (in millions)
  • Table 5-3: Major Manufacturers' Shares of the World Vaccine Market, 2010
  • Figure 5-3: 2010 World Vaccines Market Share, by Leading Competitors
  • Table 5-4: Major Manufacturer' s Shares of the World Pediatric Vaccine Market 2010
  • Figure 5-5: Market Share of Pediatric Vaccines Market, 2010
  • Table 5-5: Major Manufacturer' s Shares of the World Adult Vaccine Market 2010
  • Figure 5-6: Market Share of Adult Vaccines Market 2010

CHAPTER SIX: ISSUES AND TRENDS

  • Table 7-1: Selected Companies/Laboratories Developing Biodefense Vaccines
Show More
Pricing
Get Notified
Email me when related reports are published